The outcast of medicine: metals in medicine--from traditional mineral medicine to metallodrugs
Frontiers in Pharmacology · 07.04.2025 · 16
DOI: 10.3389/fphar.2025.1542560 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.04.2025. Verfasst von Donghan Bai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 198 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Metals have long held a significant role in the human body and have been utilized as mineral medicines for thousands of years. The modern advancement of metals in pharmacology, particularly as metallodrugs, has become crucial in disease treatment. As the machanism of metallodurgsare increasingly uncovered, some metallodrugs are already approved by FDA and widely used in treating antitumor, antidiabetes, and antibacterial. Therefore, a thorough understanding of metallodrug development is essential for advancing future study. This review offers an in-depth examination of the evolution of mineral medicines and the applications of metallodrugs within contemporary medicine. We specifically aim to summarize the historical trajectory of metals and mineral medicines in Traditional Chinese Mineral Medicine by analyzing key historical texts and representative mineral medicines. Additionally, we discuss recent advancements in understanding metallodrugs’ mechanisms, such as protein interactions, enzyme inhibition, DNA interactions, reactive oxygen species (ROS) generation, and cellular structure targeting. Furthermore, we address the challenges in metallodrug development and propose potential solutions. Lastly, we outline future directions for metallodrugs to enhance their efficacy and effectiveness. The progression of metallodrugs has broadened their applications and contributed significantly to patient health, creating good healthcare solutions for the global population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
- Faculty of Medicine, Poznan University of Medical Sciences, Poznan, Poland.
- Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
- Department of Biochemistry and Molecular and Cellular Biology, Georgetown University, Washington, DC, United States.
- Ashdale Clinic, Cork, Ireland.
- Institute of Traditional Chinese Medicine, European University of Chinese Medicine, Horsens, Denmark.
Förderung
- NCI NIH HHS
Zitieren
APA
Bai, D., Nowak, M., Lu, D., Wang, Q., Fitzgerald, M., Zhang, H., MacDonald, R., Xu, Z., & Luo, L. (2025). The outcast of medicine: metals in medicine--from traditional mineral medicine to metallodrugs. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1542560
Vancouver
Bai D, Nowak M, Lu D, Wang Q, Fitzgerald M, Zhang H, et al. The outcast of medicine: metals in medicine--from traditional mineral medicine to metallodrugs. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1542560
BibTeX
@article{Bai2025,
author = {Bai, Donghan and Nowak, Michal and Lu, Dajun and Wang, Qiaochu and Fitzgerald, Martin and Zhang, Hui and MacDonald, Remy and Xu, Ziwen and Luo, Lu},
title = {The outcast of medicine: metals in medicine--from traditional mineral medicine to metallodrugs},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1542560}
}
EUVIMED